RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 814-820

  Khandelwal, S R ^b   Kavanagh, B D ^b   Lin, P S ^b   Truong, Q T ^b   Lu, J ^b   Abraham, D J ^a   Schmidt Ullrich, R K ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allosteric effectors of haemoglobin; Haemoglobin oxygen affinity; Radiosensitizer; RSR13; Tumour hypoxia

Indexed keywords

CARBOGEN; EFAPROXIRAL; HEMOGLOBIN; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL EXPERIMENT; ARTICLE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION;

ALLOSTERIC REGULATION; ANILINE COMPOUNDS; ANIMALS; ANTISICKLING AGENTS; CARBON DIOXIDE; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; COBALT RADIOISOTOPES; FIBROSARCOMA; HEMOGLOBINS; MALE; MICE; MICE, INBRED C3H; OXYGEN; OXYHEMOGLOBINS; PROPIONIC ACIDS; PULMONARY CIRCULATION; RADIATION-SENSITIZING AGENTS; TUMOR STEM CELL ASSAY;

EID: 0005855687     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690130     Document Type: Article

References (39)

1. Abraham DJ, Peascoe RA, Randad RS and Panikker J (1992a) X-ray diffraction study of di and tetra-ligated T-state hemoglobin from high salt crystals. J Mol Biol 227: 480-492
2. Abraham DJ, Wireko FC, Randad RS, Poyart C, Kister J, Bohn BB, Liard JF and Kunert MP (1992b) Allosteric modifiers of hemoglobin: 2-[4-[[(3, 5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 31: 9141-9149
3. Brady LW, Plenk HP, Hanley JA, Glassburn JR, Kramer S and Parker RG (1981) Hyperbaric oxygen for carcinoma of the cervix - stages IIB, IIIB and IVA: results of a randomized study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7: 991-998
4. Brizel DM, Sibley GS, Prosnitz LR, Scher R and Dewhirst MW (1997) Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38: 285-290
5. Brown JM and Lemmon MJ (1990) Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumor. Cancer Res 50: 7745-7749
6. Bush RS, Jenkin RDT, Allt WEC, Beale FA, Bean H, Dembo AJ and Pringle JF (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37 (suppl. III): 302-306
7. Dewhirst MW, Ong ET, Rosner GL, Rehmus SW, Shan S, Braun RD, Brizel DM and Secomb TW (1996) Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. Br J Cancer 74 (suppl. XXVII): S241-S246
8. Dische S, Anderson PJ, Sealy R and Watson ER (1983) Carcinoma of the cervix -anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol 56: 251-255
9. Dorie MJ, Menke D and Brown JM (1993) Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen. Int J Radiat Oncol Biol Phys 28: 145-150
10. Evans JC and Bergsjo P (1965) The influence of anaemia on the results of radiotherapy in carcinoma of the cervix. Radiology 84: 709-717
11. Fletcher GL, Lindberg RD, Caderao JB and Wharton JT (1977) Hyperbaric oxygen as a radiotherapeutic adjuvant in advanced carcinoma of the uterine cervix: preliminary results of a randomized trial. Cancer 39: 617-623
12. Gatenby RA, Kessler HB, Rosenblaum JS, Coia LR, Moldofsky PJ, Hartz WH and Broder GJ (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831-838
13. Gerweck LE, Koutcher JA, Zaidi ST and Seneviratne T (1992) Energy status in the murine FSaII and MCaIV tumors under aerobic and hypoxic conditions: an in-vivo and in-vitro analysis. Int J Radiat Oncol Biol Phys 23: 557-561
14. Goda F, O'Hara JA, Rhodes ES, Liu KJ, Dunn JF, Bacic G and Swartz HM (1995) Changes of oxygen tension in experiment tumors after a single dose of X-ray irradiation. Cancer Res 55: 2249-2252
15. Hall EJ (1994) Radiobiology for the Radiologist, 4th edn, pp. 133-152. JB Lippincott: Philadelphia
16. Hirst DG and Wood PJ (1987) The influence of haemoglobin affinity for oxygen on tumour radiosensitivity. Br J Cancer 55: 487-491
17. Hirst DG and Wood PJ (1989) Chlorophenoxy acetic acid derivatives as hemoglobin modifiers and tumor radiosensitizers. Int J Radiat Oncol Biol Phys 16: 1183-1186
18. Hirst DG, Wood PJ and Schwartz HC (1987) The modification of hemoglobin affinity for oxygen and tumor radiosensitivity by antilipidemic drugs. Radiat Res 112: 164-172
19. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26: 43-50
20. Horsman MR, Chaplin DJ and Overgaard J (1991) The use of blood flow modifiers to improve the treatment response of solid tumors. Radiother Oncol 20 (suppl.): 47-52
21. Horsman MR, Khalil AA, Siemann DW, Grau C, Hill SA, Lynch EM. Chaplin DJ and Overgaard J (1994) Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. Int J Radiat Oncol Biol Phys 29: 439-442
22. Jain RK (1988) Determinants of tumor blood flow. Cancer Res 48: 2641-2658
23. Kavanagh BD, Khandelwal SR, Schmidt-Ullrich RK, Roberts JD, Pearlman AD, Shaw EG, Venitz J and Gerber MJ (1997) A phase Ib study to evaluate repeated daily intravenous doses of RSR13 administered to cancer patients receiving concurrent radiation therapy (abstract). Proceedings of the 39th Annual ASTRO Meeting. Int J Radiat Oncol Biol Phys 39: 330S
24. Khandelwal SR, Randad RS, Lin PS, Meng H, Pittman RN, Kontos HA, Choi SC, Abraham DJ and Schmidt-Ullrich R (1993) Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am J Physiol 265: H1450-H1453
25. Khandelwal SR, Lin PS, Hall CE, Truong QT, Lu J, Laurent JJ, Joshi GS, Abraham DJ and Schmidt-Ullrich RK (1996) Increased radiation response of Fsall fibrosarcomas in C3H mice following administration of an allosteric effector of hemoglobin-oxygen affinity. Radiat Oncol Invest 4: 51-59
26. Moulder JE and Rockwell S (1984) Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10: 695-712
27. Nordsmark M, Overgaard M and Overgaard J (1996a) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-39
28. Nordsmark M, Hoyer M, Keller J, Nielsen OS, Jensen OM and Overgaard J (1996b) The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 35: 701-708
29. 32P NMR for non-invasive evaluation of tumor metabolic status. Int J Radiat Oncol Biol Phys 12: 793-799
30. Overgaard J (1994) Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol Res 6: 509-518
31. Overgaard J, Hansen HS, Andersen AP, Hjelm-Hansen M, Jorgensen K, Sandberg E, Berthelsen A, Hammer R and Pedersen M (1989) Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 16: 1065-1068
32. Randad RS, Mahran MA, Mehanna AS and Abraham DJ (1991) Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. J Med Chem 34: 752-757
33. Rice L, Urano M and Suit HD (1980) The radiosensitivity of a murine fibrosarcoma as measured by three cell survival assays. Br J Cancer 41 (suppl. 4): 240-244
34. Siemann DW and Macler LM (1986) Tumor radiosensitization through reductions in hemoglobin affinity. Int J Radiat Oncol Biol Phys 12: 1295-1297
35. Siemann DW, Hill RP, Bush RS and Chhabra P (1979) The in vivo radiation response of an experimental tumor: the effect of exposing tumor-bearing mice to a reduced oxygen environment prior to but not during irradiation. Int J Radiat Oncol Biol Phys 5: 61-68
36. Teicher BA, Ara G, Emi Y, Kakeji Y, Ikebe M, Machara Y and Buxton D (1996) RSR13: effects on tumor oxygenation and response to therapy. Drug Dev Res 38: 1-11
37. Van Putten LM and Kallman RF (1968) Oxygenation status of a transplantable tumor during fractionated radiotherapy. J Natl Cancer Inst 40: 441-451
38. Ward AJ and Dixon B (1979) Carcinoma of the cervix: results of a hyperbaric oxygen trial associated with the use of the cathetron. Clin Radiol 30: 383-387
39. Wireko FC, Kellogg GE and Abraham DJ (1991) Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors. J Med Chem 34: 758-767